Corbus Pharmaceuticals Holdings, Inc. (CRBP) Free cash flow 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$64.5MFY2025 · since FY2016: -$13.9M → -$64.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.5M | -54.3% |
| FY2024 | -$41.8M | -15.8% |
| FY2023 | -$36.1M | +3.9% |
| FY2022 | -$37.6M | +22.1% |
| FY2021 | -$48.2M | +51.8% |
| FY2020 | -$100.2M | -106.7% |
| FY2019 | -$48.5M | -49.7% |
| FY2018 | -$32.4M | -13.6% |
| FY2017 | -$28.5M | -104.7% |
| FY2016 | -$13.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice